Craniofacial deformities (CFDs) develop following oncological resection, trauma, or
congenital disorders. Trauma is one of the top five causes of death globally, with rates …

Dental pulp represents a promising and easily accessible source of mesenchymal stem cells
for clinical applications. Many studies have investigated the use of human dental pulp stem …

Bone tissue engineering (BTE) is a promising approach for repairing and regenerating
damaged bone tissue, using stem cells and scaffold structures. Among various stem cell …

Introduction Human adult dental pulp stem cells (hDPSC) and stem cells from human
exfoliated deciduous teeth (SHED) hold promise in bone regeneration for their easy …

Bone loss is a common problem that ranges from small defects to large defects after trauma,
surgery, or congenital malformations. The oral cavity is a rich source of mesenchymal …

Background: Recently a greater interest in tissue engineering for the treatment of large bone
defect has been reported. The aim of the present systematic review and meta-analysis was …

Dental pulp stem cells (DPSCs) are a type of mesenchymal stem cells that can differentiate
into odontoblast-like cells and protect the pulp. The differentiation of DPSCs can be …

Cleft alveolus, a common birth defect of the maxillary bone, affects one in 700 live births
every year. This defect is traditionally restored by autogenous bone grafts or allografts …

Clefts of the lip and/or palate are the most prevalent orofacial birth defects occurring in about
1: 700 live human births worldwide. Early postnatal surgical interventions are extensive and …

Bone defects due to trauma or diseases still pose a clinical challenge to be resolved in the
current tissue engineering approaches. As an alternative to traditional methods to restore …